Position
Chief Executive Officer
Company
City Therapeutics
CambridgeBiotechnologyHealth CareTherapeuticsDescription
City Therapeutics, Inc announced the appointment of Andrew “Andy” Orth as chief executive officer and director. With more than 25 years of experience in biopharmaceutical research, development, and commercialization, Mr Orth will lead the company as it advances into the clinical and commercial stages of development, focusing on breakthrough therapeutic innovations for a range of diseases.
Quick answer
City Therapeutics Appoints Andrew Orth as Chief Executive Officer (January 7, 2025). City Therapeutics is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Executive Officer at City Therapeutics?
- City Therapeutics named Andrew Orth Chief Executive Officer, announced January 7, 2025.
- What did City Therapeutics announce on January 7, 2025?
- City Therapeutics, Inc announced the appointment of Andrew “Andy” Orth as chief executive officer and director. With more than 25 years of experience in biopharmaceutical research, development, and commercialization, Mr Orth will lead the company as it advances into the clinical and commercial stages of development, focusing on breakthrough therapeutic innovations for a range of diseases.
- What does City Therapeutics do?
- City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines.
- Where is City Therapeutics based?
- City Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Tarsier Pharma (January 7, 2025), RyCarma Therapeutics (January 7, 2025), AiCuris Anti-infective Cures AG (January 8, 2025) and Centessa Pharmaceuticals plc (January 8, 2025) also announced leadership changes within 45 days of City Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
- RyCarma Therapeutics, Inc. Unveils New Leadership and Introduces New Program in Heart Failure (January 7, 2025)
- Aicuris Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer (January 8, 2025)
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- Alltrna Appoints Dr. Nerissa Kreher as Chief Medical Officer (CMO) (January 6, 2025)
- Actio Biosciences Appoints Cayce Denton as Chief Financial Officer (January 8, 2025)
Who to call at City Therapeutics, and when
A new leader at City Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day City Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at City Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at City Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment City Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
City Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.